The scope of under- and overtreatment in older adults with cancerOctober 1, 2020Breast CancerGenitourinary CancerLung CancerMelanomaRare DiseasesOncology
Survey quantifies COVID-19’s impact on oncologySeptember 20, 2020COVID-19 UpdatesBreast CancerLung CancerGenitourinary CancerMelanomaAMLMultiple Myeloma
COVID-19 prompts ‘democratization’ of cancer trialsSeptember 16, 2020COVID-19 UpdatesGenitourinary CancerLung CancerMelanomaRare DiseasesOncology
Immunotherapy should not be withheld because of sex, age, or PSAugust 27, 2020Lung CancerMelanomaBreast CancerGenitourinary CancerOncology
Aspirin may accelerate cancer progression in older adultsAugust 27, 2020Breast CancerGenitourinary CancerLung CancerMelanomaOncology
COVID-19 impact: Less chemo, immune checkpoint inhibitors, and steroidsAugust 14, 2020Genitourinary CancerLung CancerMelanomaCOVID-19 Updates
Artificial intelligence matches cancer genotypes to patient phenotypesAugust 10, 2020Breast CancerLung CancerMelanomaGenitourinary CancerOncology
Study: Immune checkpoint inhibitors don’t increase risk of death in cancer patients with COVID-19August 7, 2020Lung CancerCOVID-19 UpdatesMelanomaGenitourinary CancerOncology
Hepatitis screening now for all patients with cancer on therapyAugust 6, 2020HepatitisBreast CancerGenitourinary CancerLung CancerMelanomaOncology
OK to treat many cancer patients despite pandemic, says ESMOJuly 31, 2020COVID-19 UpdatesBreast CancerGenitourinary CancerLung CancerMelanomaOncology
Personalized cancer vaccine may enhance checkpoint inhibitor activityJune 25, 2020Breast CancerGenitourinary CancerMelanomaLung CancerOncology
Study evaluates number of needed to refer, biopsy for diagnosing a melanomaJune 22, 2020MelanomaOncology
